Journal of Acupuncture Research

Korean Acupuncture & Moxibustion Medicine Society (대한침구의학회)
권호 표지

Melittin Inhibits DU-145 Cell Proliferation Through Induction of Apoptosis

멜라틴이 세포자멸사 유발에 의해 DU-145 세포증식에 미치는 영향

  • Shim, Yoon-Seop (Dept. of Acupuncture & Moxibustion, College of Oriental Medicine, Kyungwon University) ;
  • Song, Ho-Sueb (Dept. of Acupuncture & Moxibustion, College of Oriental Medicine, Kyungwon University)
  • 심윤섭 (경원대학교 한의과대학 침구학교실) ;
  • 송호섭 (경원대학교 한의과대학 침구학교실)
  • Published : 2009.06.20
Download PDF
⟨ Previous Next ⟩

Abstract

목적 : 본 연구는 봉약침의 주요성분인 멜리틴이 전립선 암세포주인 DU-145 세포성장에 어떤 영향을 미치는지를 알아보기 위하여 시행하였다. 방법 : 멜리틴이 DU-145의 성장에 미치는 영향을 알아보기 위한 cell viability 측정으로는 WST-1 assay를, 세포자멸사의 관찰에는 DAPI(4,6-diamidino-2-phenylindole)와 TUNEL staining assay를 시행하였으며, 세포자멸사 조절단백질(calpain, Bax, caspase-3, -9, cleaved caspase-3, cleavaged PARP, cleaved caspase-9, Bcl-2, XIAP, cIAP2, Akt, p-Akt, MMP-2, MMP-13)의 관찰을 위하여 western blot analysis를 시행하였다. 결과 : 1. DU-145 세포에서 멜리틴을 처리한 후 세포자멸사가 유도되어 세포성장이 억제되었다. 2. 세포자멸사 관련 단백질 중 분리된 caspase-3, caspase-9은 유의한 증가를, Bcl-2, p-Akt, XIAP, cXIAP는 유의한 감소를 나타내었다. 결론 : 이상의 결과는 멜리틴이 인간 전립선암세포주인 DU-145의 세포자멸사를 유발함으로써 증식억제 효과가 있음을 나타낸 것으로, 전립선암의 예방과 치료에 대한 효과적인 치료제 개발에 도움이 될 것으로 기대된다.

Keywords

References

  1. Hill-Harmon T Murray, M Thun. Cancer statistics. CA Cancer J Clin. 2001 ; 51 : 15-36. https://doi.org/10.3322/canjclin.51.1.15
  2. Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin. 2002 ; 52 : 154-79. https://doi.org/10.3322/canjclin.52.3.154
  3. DG Bostwick, J Qian. Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia. Urology. 2001 ; 58 : 91-3. https://doi.org/10.1016/S0090-4295(01)01248-1
  4. BJ Feldman, D Feldman. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001 ; 1 : 34-45. https://doi.org/10.1038/35094009
  5. Feldman BJ, Feldman D. The development of androgenin dependent prostate cancer. Nat Rev Cancer. 2001 ; 1 : 34-45. https://doi.org/10.1038/35094009
  6. Y Akao, S Kusakabe, Y Banno, M Kito, Y Nakagawa, K Tamiya-Koizumi, M Hattori, M Sawada, Y Hirabayasi, N Ohishi, Y Nozawa. Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells. Biochem Biophys Res Commun. 2002 ; 294 : 363-70. https://doi.org/10.1016/S0006-291X(02)00462-X
  7. Y Akao, Y Banno, Y Nakagawa, N Hasegawa, TJ Kim, T Murate, Y Igarashi, Y Nozawa. High expression of sphingosine kinase 1 and SIP receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecininduced up-regulation. Biochem Biophys Res Commun. 2006 ; 342 : 1284-90. https://doi.org/10.1016/j.bbrc.2006.02.070
  8. K Mizutani, K Matsumoto, N Hasegawa, T Deguchi, Y Nozawa. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT- sensitive LNCaP cells. Exp Oncol. 2006 ; 28 : 209-15.
  9. K Abdelmohsen, R Pullmann Jr, A Lal, HH Kim, S Galban, X Yang, JD Blethrow, M Walker, J Shubert, DA Gillespie, H Furneaux, M Gorospe. Phosphorylation of HuR by Chk2 regulates SIRTI expression. Mol Cell. 2007 ; 25 : 543-57. https://doi.org/10.1016/j.molcel.2007.01.011
  10. Keitaro Kojima, Riyako Ohhashi, Yasunori Fujita, N anako Hamada, Yukihiro Akao, Yoshinori Nozawa, Takashi Deguchi, Masafumi Ito. A role for SIRTI in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Bio chemical and Biophysical Research Communications. 2008 ; 373 : 423-8. https://doi.org/10.1016/j.bbrc.2008.06.045
  11. Kwon YB, Lee HJ, Han HJ, Mar WC, Kang SK, Yoon OB, Beitz AJ and Lee JH The water-soluble fraction of bee venom produces anti-nociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 2002 ; 71 : 191-204. https://doi.org/10.1016/S0024-3205(02)01617-X
  12. Holle L, Song W, Holle E, Wei Y, Wagner T and Yu X. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. Int J Oncol. 2003 ; 22 : 93-8.
  13. Park HJ, Lee YK, Song HS, Kim KJ, Son DJ, Lee JW and Hong JT. Melittin inhibits human prostate cancer cell growth through induction of apoptotic cell death. J Toxicol Pub Health. 2003 ; 22(1) : 31-7.
  14. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000 ; 21 : 485-95. https://doi.org/10.1093/carcin/21.3.485
  15. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor- induced cell death in prostate cancer. J Cell Biochem. 2004 ; 91 : 70-99. https://doi.org/10.1002/jcb.10707
  16. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 2001 ; 20 : 225-43. https://doi.org/10.1023/A:1015583310759
  17. Kantoff PW. New agents in the therapy of hormone-refractory patients with prostate cancer. Semin Oncol. 1995 ; 22 : (1 Suppl 1) 324.
  18. Wolf BB, Green DR. Suicidal tendencies: apoptotic cell death by caspase family proteinase. J Biol Chem. 1999 ; 274, 200 : 49-52.
  19. Simon HU, Haj-Heyia A and Levi Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis, 2000 ; 5 : 415-8. https://doi.org/10.1023/A:1009616228304
  20. Wyllie AH. The genetic regulation of apoptosis. Curr Opin Genet Dev. 1995 ; 5(1) : 97-104. https://doi.org/10.1016/S0959-437X(95)90060-8
  21. Green DR and Reed JC. Mitochondria and Apoptosis. Science. 1998 ; 281 : 1309-12. https://doi.org/10.1126/science.281.5381.1309
  22. Thornberry NA and Lazbrik Y. Caspases : enemies within. Science. 1998 ; 281 : 1312-6. https://doi.org/10.1126/science.281.5381.1312
  23. Darmon AJ, Nicholson DW and Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T cell derived granzyme B. Nature. 1995 ; 377 : 446-8. https://doi.org/10.1038/377446a0
  24. Sedlak TW, Oltvai ZN, Yang E et al. Multiple Bcl2 family members demonstrate selective dimerization with Bax. Proc Natl Acad Sci USA 1995 ; 92 : 7834-8. https://doi.org/10.1073/pnas.92.17.7834
  25. Miyashita T and Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell. 1995 ; 80 : 293-9. https://doi.org/10.1016/0092-8674(95)90412-3
  26. Basu A and Halder S. The relationship between Bcl2, Bax and p53 consequences for cell cycle progression and cell death. Mol Hum Repro. 1998 ; 4 : 1099-109. https://doi.org/10.1093/molehr/4.12.1099
  27. Chen X, Bargonetti J and Prives C. p53 through p21 (WAF 1/ CIP I) induces Cyclin D synthesis. Cancer Research. 1995 ; 55 : 4257-62.
  28. Choi YH, Choi BT, Lee WH, Rhee SH and Par KY. Doenjang hexane fraction induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of CDK inhibitor p21 in human breast carcinoma. Oncol Rep, 2001 ; 8(5) : 1091-6.
  29. Pugazhenthi S, Nesterova A, Sable C, Heideich KA, Boxer LM, Heasley LE and Rensch JEB. Akt/protein kinase B upregulates Bcl2 expression through cAMP-response elementbinding protein. J BioI Chem. 2001 ; '275 : 10761-6.
  30. Cardone MR, Roy N, Stennicke HR, Salvesen GS, Frarke TF, Stanbridge E, Frisch S and Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998 ; 282 : 1318-21. https://doi.org/10.1126/science.282.5392.1318
  31. LaCasse EC, Baird S, Komeluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998 ; 17 : 3247-59. https://doi.org/10.1038/sj.onc.1202569
  32. Deveraux QL, Reed JC. IAP family proteinssuppressors of apoptosis. Genes Dev. 1999 ; 13 : 239-52. https://doi.org/10.1101/gad.13.3.239
  33. Fini ME, Cook JR, Mohan R. Regulation of matrix metalloproteinase gene expression. Matrix Metalloproteinases(Edited by: Edited by Parks WC Mecham RP). San Diego: Academic Press. 1998 : 299-356.
  34. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. Circ Res. 2003 ; 92 : 827-39. https://doi.org/10.1161/01.RES.0000070112.80711.3D
  35. Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov. 2002 ; 1 : 111-21. https://doi.org/10.1038/nrd726
  36. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002 ; 2 : 647-56. https://doi.org/10.1038/nrc883
  37. Benimetskaya L, Miller P, Benimetsky S et al. Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells. Mol Pharmacol. 2001 ; 60 : 129630-7.
  38. Bettaieb A, Dubrez-Daloz L, Launay S et al. Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells. Curr Med Chem Anti Cancer Agents. 2003 ; 3 : 307-18. https://doi.org/10.2174/1568011033482396
  39. Catz SD, Johnson JL, BCL-2 in prostate cancer: a mini review. Apoptosis, 2003 ; 8 : 29-37. https://doi.org/10.1023/A:1021692801278
  40. Nachshon-Kedmi M, Yannai S, Fares FA. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3' -diindolylmethane through the mitochondria pathway. Br J Cancer. 2004 ; 91 : 1358-63. https://doi.org/10.1038/sj.bjc.6602145
  41. Zu K, Ip C. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res. 2003 ; 63 : 6988-95.
  42. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenograft in vivo. Carcinogenesis. 2004 ; 25 : 83-90. https://doi.org/10.1093/carcin/bgg178
  43. Nesterov A, Ivashchenko Y, Kraft AS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene. 2002 ; 21 : 1135-40. https://doi.org/10.1038/sj.onc.1205151
  44. Dasmahapatra GP, Didolkar P, Alley MC, Ghosh S, Sausville EA, Roy KK. In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines. Clin Cancer Res. 2004 ; 10 : 5242-52. https://doi.org/10.1158/1078-0432.CCR-03-0534
  45. HS Lee, HS Song. Bee venom inhibits LNCaP cell proliferation through induction of apoptosis via inactivation of NF-$\kappa$B. Journal of acupuncture and moxibustion. 2007 ; 25(2) : 59-74.